Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL582352 | 0.86 | TDP1 (0.63) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| SCHEMBL4586692 | 0.86 | TDP1 (0.63) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| SCHEMBL28819015 | 0.84 | TDP1 (0.61) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| Potassium SCHEMBL31360984 | 0.84 | TDP1 (0.61) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| SCHEMBL83331 | 0.84 | RAB9A (0.79) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| SCHEMBL27502116 | 0.84 | TDP1 (0.61) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| SCHEMBL4655187 | 0.83 | TDP1 (0.59) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| SCHEMBL11063346 | 0.83 | TSHR (0.61) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| SCHEMBL714886 | 0.83 | RAB9A (0.61) | TDP1ALDH1A1L3MBTL1KDM4EGAA | |
| SCHEMBL14457923 | 0.83 | TDP1 (0.59) | TDP1ALDH1A1L3MBTL1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11209733-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11209734-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11204554-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-21 | — | — | US | disclosed |
| EP-3019473-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2020-02-19 | — | — | EP | disclosed |
| US-10488756-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2019-11-26 | — | — | US | disclosed |
| EP-3354641-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2019-07-17 | — | — | EP | disclosed |
| US-10234761-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2019-03-19 | — | — | US | disclosed |
| EP-2847167-B9 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2019-02-20 | — | — | EP | disclosed |
| EP-3354641-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-08-01 | — | — | EP | disclosed |
| EP-2847167-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-07-18 | — | — | EP | disclosed |
| EP-1794240-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-06-13 | — | — | EP | disclosed |
| US-7189489-B2 | Oxime ester photoiniators having a combined structure | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-03-13 | — | — | US | disclosed |
| WO-2006037728-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-04-13 | — | — | WO | disclosed |
| US-6949678-B2 | Oxime ester photoinitiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2005-09-27 | — | — | US | disclosed |
| US-20050191567-A1 | Oxime ester photoinitiators | KUNIMOTO KAZUHIKO (JP) | 2005-09-01 | — | — | US | disclosed |
| US-20040170924-A1 | Oxime ester photoiniators having a combined structure | CIBA CORPORATION | 2004-09-02 | — | — | US | disclosed |
| US-6596445-B1 | Initiators for photopolymerization of radically polymerizable compounds | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-07-22 | — | — | US | disclosed |
| US-20020020832-A1 | Photosensitive resin composition | CIBA SPECIALTY CHEMICALS CORP. | 2002-02-21 | — | — | US | disclosed |
| US-20010012596-A1 | For resist applications; thermostability, storage stability | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-09 | — | — | US | disclosed |
| US-5663212-A | Light-sensitive resin composition | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11209734-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | TDP1 3327/4885ALDH1A1 823/4885L3MBTL1 1060/4885 |
| US-10488756-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | TDP1 3327/4885ALDH1A1 823/4885L3MBTL1 1060/4885 |
| US-11204554-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | TDP1 3339/4885ALDH1A1 779/4885L3MBTL1 1093/4885 |
| US-10234761-B2 | Oxime ester photoinitiators | C9, C5, CBR3 | TDP1 3900/4885ALDH1A1 2225/4885L3MBTL1 660/4885 |
| US-11209733-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | TDP1 3327/4885ALDH1A1 823/4885L3MBTL1 1060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.